- 1Department of Neurology, Federal University of the State of Rio de Janeiro, Rio de Janeiro, Brazil
- 2Department of Medical Psychology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, Netherlands
- 3Amsterdam Diabetes Center/Department of Internal Medicine, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, Netherlands
The impact of COVID-19 on chronic pain (CP) in non-infected vulnerable South American subjects is unknown. Healthcare workers (HCWs) are at increased risk for CP. During the pandemic, many HCWs with CP kept working. Knowing how cognition is affected by CP in these subjects is an important subject for work safety. The attention domain has a pivotal role in cognition. Previously, the Continuous Visual Attention Test (CVAT) was applied to detect specific attention deficits in fibromyalgia patients. The present investigation described CP prevalence in non-infected Brazilian HCWs during the pandemic and assessed HCWs’ attentional performance with the aid of the CVAT. This study was carried out at a reference University Hospital in Rio de Janeiro, Brazil. HCWs of both sexes, aged 20 or older, were interviewed from August to December 2020. A 90-second version of the CVAT was performed. The average reaction time to correct responses and the respective intraindividual reaction time variability for correct responses to target (VRT) was determined. Omission and commission errors were also calculated. Then, for each participant we calculated the Z-scores of the CVAT variables based on the distribution of CVAT performance of 211 healthy subjects (reference-comparison group). HCWs with Z-scores > 1.64 were classified as significantly impaired. From the 154 selected HCWs, 72 reported CP during the pandemic (prevalence = 47%). Post hoc ANCOVAs showed that the average correct VRT was significantly higher in the CP group than in the non-CP group (F = 4.99, df = 1/150, p = 0.027, η2 = 0.032). The percentage of participants with impaired VRT performance was 30% (n = 21) in the CP group and 16% (n = 13) in the non-CP group. The difference between these two propositions reached significance (χ2 = 3.96, df = 1, p = 0.047). As VRT is associated with the sustained-attention subdomain, our data suggest that this subdomain is disrupted in the CP group.
Introduction
The International Association for the Study of Pain defines chronic pain (CP) as an unpleasant sensory and emotional experience that persists for more than 3 months (Raja et al., 2020). Population estimates for CP prevalence varies by case definition, ascertainment methods, time, and place. Previous studies have shown that CP affects 13–40% of adults worldwide (Mills et al., 2019). In the US, a recent survey found that 50.2 million adults (20.5%) reported pain on most days or every day (Yong et al., 2022).
It has been proposed that CP conditions can be triggered by psychosocial stressors (McBeth et al., 2005; Generaal et al., 2016; Yavne et al., 2018). However, the incidence of pain complaints did not change among New York and New Jersey residents surveyed after the World Trade Center 9/11 attacks (Raphael et al., 2020). Similarly, catastrophic events, such as earthquakes, fires, or other naturally occurring catastrophic situations have not invariably led to an increase in chronic somatic symptoms (Pillow et al., 1996). These studies suggest that not all psychological stressors will trigger or exacerbate CP. In contrast, veterans showed combat-related psychiatric symptoms closely associated with CP (Xue et al., 2015). Therefore, simultaneous or over time exposure to many stressors can potentially increase the risk for future CP.
The COVID-19 pandemic has many characteristics that could increase the prevalence and incidence of CP. Importantly, the effects of the COVID-19 pandemic on CP could manifest in both infected and non-infected individuals due to routine life and sleep disruptions and physical, psychological, and social stressors which are all factors that can contribute to the chronic pain experience (Van Houdenhove, 2000; Meints and Edwards, 2018; Varallo et al., 2022). However, the impact of COVID-19 on CP is still a matter of controversy. Colloca et al. (2021) reported pain outcome improvement during the stay-at home period in participants not diagnosed with COVID-19. Mun et al. (2022) showed that individuals with chronic pain overall did not experience significant exacerbation of pain and opioid misuse during the COVID-19 pandemic. In contrast, another study in the US showed that approximately 25–30% of individuals reported exacerbation of pain severity and pain interference since the COVID-19 outbreak (Mun et al., 2021). Similarly, a research in Spain reported adverse effects of the COVID-19 pandemic on CP (Nieto et al., 2020). In accordance of the latter studies we hypothesize that the COVID-19 pandemic may cause an increase in new-onset CP among non-infected subjects.
If little is known about the effect of the COVID-19 pandemic on CP, even less is known about its impact on specific vulnerable populations. In general, healthcare workers (HCWs) are at increased risk for development of CP and constitute a vulnerable population (Barski et al., 2020). Individuals working in low- and middle-income countries are particularly disadvantaged due to limited resources and shortage of healthcare workers. During the pandemic, many HCWs kept working despite suffering from CP (Ozen and Cakmak, 2021). Therefore, we conducted a study to address this issue. We sought to provide a general exploratory perspective of the incidence and prevalence of CP among HCWs based on a cross-sectional face-to-face survey in one of the most affected South American countries.
As mentioned, HCWs are particularly vulnerable to CP during the current pandemic. An additional question that arises is how cognition is affected by CP in these subjects. This is important, as CP affecting cognition might lead to work-related errors. Interestingly, studies using functional MRI reported that CP patients have lower dorsolateral prefrontal cortex (DLPFC) and the posterior parietal cortex (PPC) connectivity when compared to controls (Apkarian et al., 2004; Baliki et al., 2008; Seminowicz et al., 2011; Pujol et al., 2014; Seminowicz and Moayedi, 2017). Attention is one of the core functions of the DLPFC and PPC. This was demonstrated by a study measuring regional FDG-PET metabolism during a visual attention test, the Continuous Visual Attention Test (CVAT) (Schmidt et al., 2008a). In a previous investigation, the CVAT was applied to assess attentional performance in fibromyalgia patients (Schmidt et al., 2008b), showing that CP patients had a poorer performance compared to non-CP subjects. This suggests that CP might affect HCWs’ attentional performance and the CVAT could be helpful to assess this.
This investigation sought to describe the prevalence of CP among non-infected Brazilian HCWs during the COVID-19 pandemic. Then, with the aid of the CVAT, we assessed the attentional performance of HCWs with CP and compared their average to those without CP. Finally, we applied categorial cutoffs to the two groups to verify whether the percentage of subjects with relevant impaired attention was higher in HCWs with CP. We expect that the timely recognition of attention deficits among workers with CP who are required to keep working would allow for more appropriate treatment to mitigate the potential impact of CP on work safety.
Materials and methods
Initial sample
The study was carried out among HCWs at the University Hospital of Federal University of Rio de Janeiro, located in the city of Rio de Janeiro, Brazil. Two hundred (200) HCWs, of both sexes, aged 20 or older, were interviewed from August to December 2020. The healthcare workers (HCWs) who worked in the hospital during this research period were invited to participate in the present study by email. The researchers informed the study aims and the procedure of data collection. After this invitation, those who agreed to participate were contacted by the research team.
A specifically developed questionnaire, completed by participants with their identification details (age/sex/race/education level), questioned whether they suffered from pain and, if so, for how long (duration/if appeared before or after the pandemic) have they felt such pain and where (head, lumbar, cervical, inferior or superior members).
The study was conducted in accordance with the Declaration of Helsinki, and all participants provided written informed consent. The local ethical review committee approved the research protocol (39365120.8.0000.5258).
Inclusion and exclusion criteria
We included HCWs with pain complaints that had persisted for more than 3 months and that were not related to trauma, surgery, or cancer. We excluded participants who reported using any of the following drugs: antidepressants, benzodiazepines, modafinil, opioids, gabapentin, and pregabalin. We also excluded subjects with previous or current COVID-19 diagnosis, individuals with neurological or psychiatric conditions, and those who handed over incomplete questionnaires.
Evaluation of attention performance
The 90-second version of the CVAT was used. The CVAT is a computerized Go/No-Go test (Figure 1) for this study, and a fully description can be found in a previous publication (van Duinkerken et al., 2021). In brief, target and non-target stimuli were presented at the center of a screen for 250 milliseconds, with a 750- millisecond interstimulus interval. Of the 90 trials, 72 (80%) were targets, and 18 (20%) were non-targets.
Figure 1. Continuous Visual Attention Test (CVAT). This version of the CVAT begins with written instructions on the screen (A) The computer alternately displays the indicated figures at the center of the screen. The participant must press the spacebar using her/his dominant hand as fast as she/he can whenever the star appears at the center of the screen. The participants are instructed to not press the spacebar if the other figure appears. These instructions are read aloud by the interviewer. The target (B) remains on screen for 250 milliseconds (ms). The non-target (C) also remains on screen for 250 ms. There was one block with 90 trials (two Figures – both targets and non-targets – were presented, one each time). The interstimulus interval was 1 s. The entire test took 1.5 min to be completed. Variables: Omission errors (OE), Commission errors (CE), Average reaction time for correct responses (RT), and reaction time variability (VRT). The CVAT is open for registered psychologists upon request. English, Portuguese, and Spanish versions are available.
Subjects were seated in front of the computer in such a way as to allow the dominant hand to be placed over the keyboard. The distance to the center of the monitor was of approximately 50 cm. Instructions were shown on the screen, then reinforced by the examiner. A practice session, in which no error could be made, was presented before testing commenced. In case of error, the practice session was automatically repeated.
The average reaction time for correct responses to target was calculated for each participant. Additionally, as reaction times vary throughout the test, intraindividual reaction time variability for all correct responses to target was determined. VRT was estimated by the standard deviation (SD) of each person’s responses calculated over all correct RT trials, because SD is considered the simplest and is the most used measure of VRT (Saville et al., 2011; Dykiert et al., 2012). In addition, several studies have reported that different variability metrics tended to produce similar results (Myerson et al., 2007; Saville et al., 2011; Dykiert et al., 2012). However, one problem that affects this metric is that some studies have described a relationship between mean RT and SD in a some neurological diseases (Wagenmakers and Brown, 2007; Tamm et al., 2012). To account for any possible association between mean RT and SD we also calculated the coefficient of variation, which is the ratio of VRT (i.e., SD) to the individual mean correct RT. Omission errors (no response to target) and commission errors (response to a non-target) were also calculated.
Reference group
To determine CVAT cutoffs, we used previous data obtained from a large sample of healthy subjects (n = 211). These subjects completed the CVAT between June and December 2019. They all had normal neurological exams, absence of visual and hearing impairments, no psychiatric complaints, were not using psychiatric medication, and had a mini-mental status examination in the normal range.
Statistical analysis
Demographic variables were analyzed using an independent sample t-test for normally distributed variables, a Kruskal–Wallis test for non-normally distributed variables, or a χ2 test for categorical variables.
First, a MANCOVA was performed including correct reaction time, correct reaction time variability, omission and commission errors as dependent variables, and presence of CP (yes or no) as independent variables. The same statistical procedures were also performed replacing VRT and RT with the respective coefficient of variability (VRT/RT). Age and sex were used as covariates. Box’s M test was used to assess the homogeneity of covariance matrices. In case of a significant overall MANCOVA, the post hoc ANCOVA of each dependent variable was checked for statistical significance. A significant MANCOVA suggests that at least one dependent variable is different between the groups, thus allowing for further post hoc testing. For MANCOVA and each one of the univariate ANCOVAs, η2 (Eta squared) was computed to calculate the effect size of results (Cohen, 1973). Cohen suggests that η2 = 0.01 should be considered a “small” effect size, 0.06 represents a “medium” effect size, and 0.14 a “large” effect size (Cohen, 1973).]. Corrections for multiple comparisons were performed with the Bonferroni method. A MANCOVA/ANCOVA approach was chosen as it has been shown to give robust results even when variables are not normally distributed (Olejnik and Algina, 1984). A p < 0.05 was considered statistically significant.
To investigate the number of HCWs with relevant attentional deficits, we calculated the participants’ Z-scores for each CVAT variable considering the means and the standard deviations (SD) of the reference group. A Z-score of 1.64 indicates that the performance is 1.64 SD to the right of the mean of the reference group, which represents a cumulative probability of 95%. In other words, a Z-score of 1.64 or higher indicates that performance is in the 5th percentile of the reference group. Therefore, for each CVAT variable, a participant’s Z-score greater than 1.64 was classified as being significantly impaired. Differences in the proportion of subjects with attentional impairments between HCWs with and without CP were tested with chi-square tests.
Results
Participants
From August to December 2020, 200 HCWs were interviewed and tested. After applying the exclusion criteria, 154 participants were included (a total of 46 participants – 7 associated with the use of medications – were excluded). Among these 154 subjects, 72 reported CP that lasted 3 months or more during the pandemic (57 participants reported CP starting prior to the pandemic and 15 CP starting during the pandemic). Demographic variables are shown in Table 1.
Prevalence and incidence
From the 154 participants, 72 reported CP during the pandemic – a 47% prevalence. As 57 subjects reported CP before the pandemic, 97 participants did not have CP before the pandemic. Among these 97 subjects, 15 reported CP starting during the COVID-19 pandemic. This gives a 15.4% incidence in 5 months (Figure 2). As 57 subjects had CP before the pandemic among the selected sample (n = 154), this gives a 37% prevalence before the pandemic.
Figure 2. Flowchart of the study design. HCWs, healthcare workers; CVAT, Continuous Visual Attention Test; CP, chronic pain.
Mean group differences in attentional performance
Figure 3 shows the average reaction time, reaction time variability, and commission and omission errors dividing the participants into CP ad non-CP, based on presence of CP at the moment of the CVAT assessment. The overall MANCOVA reached statistical significance (F = 2.76, df: 4/147, p = 0.031, η2 = 0.07). The post hoc ANCOVAs showed that the average correct response time variability was, statistically speaking, significantly higher in the CP group than in the non-CP group (F = 4.99, df: 1/150, p = 0.027, η2 = 0.032). Although the average reaction time and the number of omission errors were also higher in the CP vs. non-CP group, none had statistical significance.
Figure 3. Continuous Visual Attention Test (CVAT) performance. Bar graphs displaying mean with standard deviation per group for each CVAT variable. Chronic pain (CP) patients present higher reaction time variability than non-CP participants.
When the VRT and RT were replaced with the corresponding coefficient of variability (VRT/RT), the effect of CP on attention performance remained significant (MANCOVA, F = 3.03, df = 3/148, p = 0.031, η2 = 0.06). The post hoc ANCOVAs showed that the coefficient of variability was significantly higher in the CP group than in the non-CP group (F = 5.50, df: 1/150, p = 0.020, η2 = 0.035) whereas omission and commission errors did not reach significance.
Number of healthcare workers with impaired attention
Based on the VRT distribution of the 211 subjects of the reference group, we determined the number of HCWs with Z-scores > 1.64 (i.e., subjects below the 5th percentile). Twenty-one participants (30%) with CP and 16% (n = 13) without CP had VRTs in the impaired range (Z-score > 1.64). The difference between these two proportions reached significance (χ2 = 3.96, df = 1, P = 0.047). We did not use Fisher’s Exact Test because none of the cell counts was less than 5. As the total N for the 2 × 2 chi-square table was greater than 40, the Yates continuity correction was not used.
Discussion
We showed that CP prevalence increased among non-infected Brazilian HCWs during the COVID-19 pandemic. These HCWs kept working despite the presence of CP. Based on average VRT those with CP showed a significant deficit in the ability to sustain attention compared to HCWs without CP. The percentage of impaired VRT subjects in the CP group was significantly higher than that of the non-CP group.
A previous study estimated that CP prevalence reached 38% in Brazil (de Souza et al., 2017). The same study showed a 40% prevalence specifically in the Southeast region, including the city of Rio de Janeiro (de Souza et al., 2017). In line with these findings, we found a 37% CP prevalence before the current pandemic. When we considered the new cases during the pandemic, CP prevalence rose to 47%, i.e., higher than before the COVID-19 outbreak. In the current study, CP new cases during the pandemic reached 15% in 5 months (15 new cases), which is considerably higher than the incidence reported in other countries. However, these data should be interpreted with caution due to several limitations. First, the small sample size challenges while evaluating populational incidence and prevalence. Secondly, the same individuals used to calculate CP incidence were also present in estimating CP prevalence during the pandemic. However, for the first time, we described a preliminary perspective of CP prevalence during the COVID-19 outbreak in a South American country, despite these limitations. Following the hypotheses raised by Clauw et al.(Clauw et al., 2020), these preliminary data show that the COVID-19 pandemic increased CP prevalence among HCWs, probably because of high psychosocial stressors extending over many months, as experienced by these workers during the outbreak.
The high frequency of CP among HCWs who had to keep working during the COVID-19 pandemic raised a concern about their actual cognitive abilities. Here we found significant attentional deficits during the performance of the CVAT by HCWs with CP. Indeed, there are several studies on the relation between brain alterations and maladaptive cognitive and emotional factors in patients with CP, due to the presence of a cerebral plastic time-dependent reorganization related to the maintenance of pain (Malfliet et al., 2017). However, it should be mentioned that changes in plasticity are not the only mechanisms that can underlie these phenomena. Central sensitization has been described in CP and was found to be correlated with gray matter volume decrease in the DLPFC as well as changes in the PPC (Cagnie et al., 2014). Furthermore, functional MRI studies using a Go/No-Go attention task in healthy volunteers showed the activation of a network comprising the frontoparietal cognitive control regions (Bellgrove et al., 2004; MacDonald et al., 2006). Consistent with this idea, several studies have shown that persistent and long-term pain affects brain function in response to attention tasks (Baliki et al., 2008; Schmidt-Wilcke et al., 2014). In accordance with these studies, we showed that most of the HCWs with CP had significant changes in the variability of reaction times as measured with the aid of the CVAT.
Adding the coefficient of variability to the analysis allowed for the study of the VRT variable controlling for RT (Flehmig et al., 2007). The present study showed a significant difference in the coefficients of variability between CP and non-CP participants. Thus, this finding gives further support for the hypotheses that the increase in the VRT seen in the CP group is not explained by any putative increase in RT. Similarly, other studies have reported higher reaction time variability among older adults when compared to younger adults, even when group differences in response speed were statistically controlled (Hilborn et al., 2009).
Reaction time variability reaction time fluctuations during the CVAT. In this study, HWCs with CP had more significant response time fluctuations than those without CP. There is literature available to support the hypothesis that a greater VRT is observed in several neurological conditions, such as Alzheimer’s disease or mild cognitive impairment (Schmidt et al., 2020, 2021). In addition, VRT was found to predict progression of cognitive decline from healthy aging to mild cognitive impairment (Cherbuin et al., 2010; Haynes et al., 2017). Moreover, previous studies have demonstrated that higher reaction time variability is related to worse cognitive functioning in domains such as sustained-attention, memory, intelligence, and information processing speed (Hultsch et al., 2002; Epstein et al., 2011; Simões et al., 2017). Furthermore, VRT is associated with white matter integrity in healthy adults (Bellgrove et al., 2004; Bunce et al., 2013). It should be mentioned that the evidence that greater VRT is associated with central nervous system dysfunction is independent of any increase in RT (Hilborn et al., 2009). Taken together these studies support that HCWs with CP presenting higher VRTs may show worse cognitive functioning, even without increased errors or RTs. Therefore, we suggest that HCWs with CP may show significant cognitive disturbances that would interfere with workplace safety.
This study has some limitations. First, the sample size used to estimate prevalence and incidence of CP is small. Secondly, because of the small number of subjects (n = 15), we did not have enough statistical power to study HCWs that started to report CP during the pandemic separately. One limitation of the present study is that the test used here consisted of 18 non-targets. Previous studies have shown that both reaction time and variability of reaction time can be reliably measured by tests as short as 52 s with 20 items (Manuel et al., 2019). Therefore, the 90-s CVAT has sufficient targets (72) to reliably measure reaction time and variability of reaction time. Regarding accuracy, however, the maximum number of commission errors (18 non-targets) limits the possibility to capture accuracy alterations. A commonly used measure related to accuracy is d’, which represents the sum of the normalized commission and omission errors. To calculate this measure, it is imperative that there are sufficient targets and non-targets allowing for participants to make mistakes. Because of the lower number of targets and especially of non-targets in the Go/No-Go task used in this study, we were less capable of capturing accuracy. Future studies using Go/No-Go tasks of longer duration should consider the inclusion of measures derived from signal detection theory, such as d’ (Nestor et al., 1990; See et al., 1997; MacMillan and Creelman, 2005; Hautus et al., 2021).
A recent longitudinal study reported that deficits in executive functions could impair the use of appropriate pain coping strategies and facilitate the development of chronic pain (Giusti et al., 2020). Therefore, a new investigation should address the association between the presence of executive dysfunctions and CP. In addition, pain catastrophizing measurements should be investigated in a future study because pain catastrophizing is related to brain areas involved in pain attention and top-down pain inhibition (Chehadi et al., 2017). Whether the reaction time variability in CP subjects is related to a greater risk of work accidents needs to be determined in future studies. In this regard, the standard deviation of reaction time measured in a reaction test was found to be significantly correlated with safe driving indexes [e.g., (Altarabichia et al., 2020)].
The strength of this study is that a reaction-time task (CVAT) was able to identify sustained-attention deficits in HCWs with CP. The CVAT is quick (90 s), requires little training, involves minimal linguistic capabilities, provides cost-efficient diagnostics (open to licensed psychologists), and has clear guidelines and norms. It should be mentioned that a previous study demonstrated that attentional performance might help predict which patients with CP will respond to duloxetine treatment even before they can demonstrate subjective improvements in pain perception (Schmidt et al., 2008b).
In conclusion, we demonstrated that a great number of HCWs with CP have a profile of reaction time performance that fluctuates more, i.e., is less stable compared to their counterparts without CP. This study shows that a simple reaction-time Go/No-Go instrument could be used to detect specific attention deficits in HCWs with CP.
Data availability statement
The original contributions presented in this study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.
Ethics statement
The studies involving human participants were reviewed and approved by Plataforma Brasil (39365120.8.0000.5258). The patients/participants provided their written informed consent to participate in this study.
Author contributions
SS participated of design of the study, collected and analyzed the data, and wrote the manuscript. IA and VN participated of the conception of the study, collected data, and critically revised the manuscript. GS participated of the data analyses and critically revised the manuscript. ED, JT, and AG collected data, analyzed data, and critically revised the manuscript. All authors contributed to the article and approved the submitted version.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Altarabichia, M. G., Ahmeda, M. U., Beguma, S., Cicerib, M. R., Balzarottib, S., Biassonib, F., et al. (2020). “Reaction time variability association with safe driving indexes,” in Proceedings of 8th Transport Research Arena, (Helsinki).
Apkarian, A. V., Sosa, Y., Sonty, S., Levy, R. M., Harden, R. N., Parrish, T. B., et al. (2004). Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J. Neurosci. 24, 10410–10415. doi: 10.1523/JNEUROSCI.2541-04.2004
Baliki, M. N., Geha, P. Y., Apkarian, A. V., and Chialvo, D. R. (2008). Beyond feeling: chronic pain hurts the brain, disrupting the default-mode networks dynamics. J. Neurosci. 28, 1398–1403. doi: 10.1523/JNEUROSCI.4123-07.2008
Barski, L., Shafat, T., Buskila, Y., Amital, H., Makulin, Y., Shvarts, B., et al. (2020). High prevalence of fibromyalgia syndrome among Israeli nurses. Clin. Exp. Rheumatol. 38, 25–30.
Bellgrove, M. A., Hester, R., and Garavan, H. (2004). The functional neuroanatomical correlates of response variability: evidence from a response inhibition task. Neuropsychologia 42, 1910–1916. doi: 10.1016/j.neuropsychologia.2004.05.007
Bunce, D., Bielak, A. A., Cherbuin, N., Batterham, P. J., Wen, W., Sachdev, P., et al. (2013). Utility of intraindividual reaction time variability to predict white matter hyperintensities: a potential assessment tool for clinical contexts? J. Int. Neuropsychol. Soc. 19, 971–976. doi: 10.1017/S1355617713000830
Cagnie, B., Coppieters, I., Denecker, S., Six, J., Danneels, L., and Meeus, M. (2014). Central sensitization in fibromyalgia? a systematic review on structural and functional brain MRI. Sem. Arthritis Rheumatism 44, 68–75. doi: 10.1016/j.semarthrit.2014.01.001
Chehadi, O., Suchan, B., Konietzny, K., Köster, O., Schmidt-Wilcke, T., and Hasenbring, M. I. (2017). Gray matter alteration associated with pain catastrophizing in patients 6 months after lumbar disk surgery: a voxel-based morphometry study. Pain Rep. 2:e617. doi: 10.1097/PR9.0000000000000617
Cherbuin, N., Sachdev, P., and Anstey, K. J. (2010). Neuropsychological predictors of transition from healthy cognitive aging to mild cognitive impairment: the PATH through life study. Am. J. Geriatric Psychiatry 18, 723–733. doi: 10.1097/jgp.0b013e3181cdecf1
Clauw, D. J., Häuser, W., Cohen, S. P., and Fitzcharles, M. A. (2020). Considering the potential for an increase in chronic pain after the COVID-19 pandemic. Pain 161, 1694–1697. doi: 10.1097/j.pain.0000000000001950
Cohen, J. (1973). Eta-squared and partial eta-squared in fixed factor ANOVA designs. Educ. Psychol. Measurement 33, 107–112. doi: 10.1016/j.bone.2009.03.654
Colloca, L., Thomas, S., Yin, M., Haycock, N. R., and Wang, Y. (2021). Pain experience and mood disorders during the lockdown of the COVID-19 pandemic in the United States: an opportunistic study. Pain Rep. 6:e958. doi: 10.1097/PR9.0000000000000958
de Souza, J. B., Grossmann, E., Perissinotti, D. M. N., de Oliveira Junior, J. O., da Fonseca, P. R. B., and Posso, I. P. (2017). Prevalence of chronic pain, treatments, perception, and interference on life activities: brazilian population-based survey. Pain Res. Manag. 2017:4643830. doi: 10.1155/2017/4643830
Dykiert, D., Der, G., Starr, J. M., and Deary, I. J. (2012). Age differences in intra-individual variability in simple and choice reaction time: systematic review and meta-analysis. PLoS One 7:e45759. doi: 10.1371/journal.pone.0045759
Epstein, J. N., Langberg, J. M., Rosen, P. J., Graham, A., Narad, M. E., Antonini, T. N., et al. (2011). Evidence for higher reaction time variability for children with ADHD on a range of cognitive tasks including reward and event rate manipulations. Neuropsychology 25, 427–441. doi: 10.1037/a0022155
Flehmig, H. C., Steinborn, M. B., Langner, R., Scholz, A., and Westhoff, K. (2007). Assessing intraindividual variability in sustained attention: reliability, relation to speed and accuracy, and practice effects. Psychol. Sci. 49:132.
Generaal, E., Vogelzangs, N., Macfarlane, G. J., Geenen, R., Smit, J. H., de Geus, E. J. C. N., et al. (2016). Biological stress systems, adverse life events and the onset of chronic multisite musculoskeletal pain: a 6-year cohort study. Ann. Rheumatic Dis. 75, 847–854. doi: 10.1136/annrheumdis-2014-206741
Giusti, E. M., Manna, C., Varallo, G., Cattivelli, R., Manzoni, G. M., Gabrielli, S., et al. (2020). The predictive role of executive functions and psychological factors on chronic pain after orthopaedic surgery: a longitudinal cohort study. Brain Sci. 10:685. doi: 10.3390/brainsci10100685
Hautus, M. J., Macmillan, N. A., and Creelman, C. D. (2021). Detection Theory: A User’s Guide, 3rd Edn. London: Routledge, doi: 10.4324/9781003203636
Haynes, B. I., Bauermeister, S., and Bunce, D. (2017). A systematic review of longitudinal associations between reaction time intraindividual variability and age-related cognitive decline or impairment, dementia, and mortality. J. Int. Neuropsychol. Soc. 23, 431–445. doi: 10.1017/S1355617717000236
Hilborn, J. V., Strauss, E., Hultsch, D. F., and Hunter, M. A. (2009). Intraindividual variability across cognitive domains: investigation of dispersion levels and performance profiles in older adults. J. Clin. Exp. Neuropsychol. 31, 412–424. doi: 10.1080/13803390802232659
Hultsch, D. F., MacDonald, S. W. S., and Dixon, R. A. (2002). Variability in reaction time performance of younger and older adults. J. Gerontol. Series B Psychol. Sci. Soc. Sci. 57, 101–115.
MacDonald, S. W. S., Nyberg, L., and Bäckman, L. (2006). Intra-individual variability in behavior: links to brain structure, neurotransmission and neuronal activity. Trends Neurosci. 29, 474–480. doi: 10.1016/j.tins.2006.06.011
MacMillan, N. A., and Creelman, C. D. (2005). Detection Theory: A user’s guide, 2nd Edn. New York, NY: Psychology Press.
Malfliet, A., Coppieters, I., van Wilgen, P., Kregel, J., Pauw, R., Dolphens, M., et al. (2017). Brain changes associated with cognitive and emotional factors in chronic pain: a systematic review. Eur. J. Pain 21, 769–786. doi: 10.1002/ejp.1003
Manuel, A. L., Foxe, D., Bradshaw, N., Cordato, N. J., Hodges, J. R., Burrell, J. R., et al. (2019). Sustained attention failures on a 3-min reaction time task is a sensitive marker of dementia. J. Neurol. 266, 1323–1331. doi: 10.1007/s00415-019-09261-9
McBeth, J., Chiu, Y. H., Silman, A. J., Ray, D., Morriss, R., Dickens, C., et al. (2005). Macfarlane, Hypothalamic-pituitary-adrenal stress axis function and the relationship with chronic widespread pain and its antecedents. Arthritis Res. Therapy 7, R992–R1000. doi: 10.1186/ar1772
Meints, S. M., and Edwards, R. R. (2018). Evaluating psychosocial contributions to chronic pain outcomes. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 87, 168–182.
Mills, S. E. E., Nicolson, K. P., and Smith, B. H. (2019). Chronic pain: a review of its epidemiology and associated factors in population-based studies. Br. J. Anaesthesia 123, e273–e283. doi: 10.1016/j.bja.2019.03.023
Mun, C. J., Campbell, C. M., McGill, L. S., and Aaron, R. V. (2021). The early impact of COVID-19 on chronic pain: a cross-sectional investigation of a large online sample of individuals with chronic pain in the United States. April to May, 2020. Pain Med. 22, 470–480. doi: 10.1093/pm/pnaa446
Mun, C. J., Campbell, C. M., McGill, L. S., Wegener, S. T., and Aaron, R. V. (2022). Trajectories and individual differences in pain, emotional distress, and prescription opioid misuse during the COVID-19 pandemic: a one-year longitudinal study. J. Pain 23, 1234–1244. doi: 10.1016/j.jpain.2022.02.005
Myerson, J., Robertson, S., and Hale, S. (2007). Aging and intraindividual variability in performance: analyses of response time distributions. J. Exp. Anal. Behav. 88, 319–337.
Nestor, P. G., Faux, S. F., McCarley, R. W., Shenton, M. E., and Sands, S. F. (1990). Measurement of visual sustained attention in schizophrenia using signal detection analysis and a newly developed computerized CPT task. Schizophrenia Res. 3, 329–332. doi: 10.1016/0920-9964(90)90018-3
Nieto, R., Pardo, R., Sora, B., Feliu-Soler, A., and Luciano, J. V. (2020). Impact of COVID-19 lockdown measures on spanish people with chronic pain: an online study survey. J. Clin. Med. 9:3558. doi: 10.3390/jcm9113558
Olejnik, F., and Algina, J. (1984). Parametric ANCOVA and the rank transform ANCOVA when the data are conditionally non-normal and heteroscedastic. J. Educ. Statistics 9, 129–149.
Ozen, S., and Cakmak, E. (2021). Prevalence of chronic low back pain and associated risk factors in healthcare workers during the Covid-19 pandemic. COJ Nurse Healthcare 7, 810–818 doi: 10.31031/COJNH.2021.07.000672
Pillow, D. R., Zautra, A. J., and Sandler, I. (1996). Major life events and minor stressors: identifying mediational links in the stress process. J. Personal. Soc. Psychol. 70, 381–394. doi: 10.1037//0022-3514.70.2.381
Pujol, J., Macià, D., Fontanals, A. G., Hinojo, L., Solà, M., Blanco, S. G., et al. (2014). The contribution of sensory system functional connectivity reduction to clinical pain in fibromyalgia. Pain 155, 1492–1503. doi: 10.1016/j.pain.2014.04.028
Raja, S. N., Carr, D. B., Cohen, M., Finnerup, N. B., Flor, H., Gibson, S., et al. (2020). The revised international association for the study of pain definition of pain: concepts, challenges, and compromises. Pain 161, 1976–1982. doi: 10.1097/j.pain.0000000000001939
Raphael, K. G., Natelson, B. H., Janal, M. N., and Nayak, S. (2020). A community-based survey of fibromyalgia-like pain complaints following the world trade center terrorist attacks. Pain 100, 131–139. doi: 10.1016/s0304-3959(02)00273-7
Saville, C. W. N., Pawling, R., Trullinger, M., Daley, D., Intriligator, J., and Klein, C. (2011). On the stability of instability: optimising the reliability of intra-subject variability of reaction times. Personal. Individual Differ. 51, 148–153.
Schmidt, G., Alvarenga, R., Manhães, A., and Schmidt, S. (2008a). Attentional performance may help to identify duloxetine responders in chronic pain fibromyalgia patients. Eur. J. Pain 21, 977–986. doi: 10.1002/ejp.997
Schmidt, G. J., Boechat, Y. E. M., van Duinkerken, E., Schmidt, J. J., Moreira, T. B., and Nicaretta, D. H. (2020). Detection of cognitive dysfunction in elderly with a low educational level using a reaction-time attention task. J. Alzheimers. Dis. 78, 1197–1205. doi: 10.3233/JAD-200881
Schmidt, S., Correa, P., Tolentino, J., Manhães, A., Felix, R., Azevedo, J., et al. (2008b). Value of combining activated brain FDG-PET and cardiac MIBG for the differential diagnosis of dementia. Clin. Nuclear Med. 33, 398–401. doi: 10.1097/RLU.0b013e3181708244
Schmidt, S. L., Boechat, Y. E. M., Schmidt, G. J., Nicaretta, D., van Duinkerken, E., and Schmidt, J. J. (2021). Clinical utility of a reaction-time attention task in the evaluation of cognitive impairment in elderly with high educational disparity. J. Alzheimers. Dis. 81, 691–697. doi: 10.3233/JAD-210151
Schmidt-Wilcke, T., Kairys, A., Ichesco, E., Fernandez-Sanchez, M. L., Barjola, P., Heitzeg, M., et al. (2014). Changes in clinical pain in fibromyalgia patients correlate with changes in brain activation in the cingulate cortex in a response inhibition task. Pain Medice 15, 1346–1358. doi: 10.1111/pme.12460
See, J. E., Warm, J. S., Dember, W. N., and Howe, S. R. (1997). Vigilance and signal detection theory: an empirical evaluation of five measures of response bias’. Hum. Factors 39, 14–29.
Seminowicz, D. A., and Moayedi, M. (2017). The dorsolateral prefrontal cortex in acute and chronic pain. J. Pain 18, 1027–1035. doi: 10.1016/j.jpain.2017.03.008
Seminowicz, D. A., Wideman, T. H., Naso, L., Hatami-Khoroushahi, Z., Fallatah, S., Ware, M. A., et al. (2011). Effective treatment of chronic low back pain in humans reverses abnormal brain anatomy and function. J. Neurosci. 31, 7540–7550.
Simões, E. N., Carvalho, A. L. N., and Schmidt, S. L. (2017). What does handedness reveal about ADHD? An analysis based on CPT performance. Res. Dev. Disabilities 65, 46–56. doi: 10.1016/j.ridd.2017.04.009
Tamm, L., Narad, M. E., Antonini, T. N., O’Brien, K. M., Hawk, L. W. Jr., and Epstein, J. N. (2012). Reaction time variability in ADHD: a review. Neurotherapeutics 9, 500–508. doi: 10.1007/s13311-012-0138-135
van Duinkerken, E., Schmidt, G., Gjorup, A., Mello, L. T. C. R., Marques, A. C., Filho, A. C., et al. (2021). Assessment of attentional functioning in health professionals of a brazilian tertiary referral hospital for COVID-19. Behav. Neurol. 2021:6655103. doi: 10.1155/2021/6655103
Van Houdenhove, B. (2000). Psychosocial stress and chronic pain. Eur. J. Pain 4, 225–228. doi: 10.1053/eujp.2000.0189
Varallo, G., Giusti, E. M., Manna, C., Castelnuovo, G., Pizza, F., Franceschini, C., et al. (2022). Sleep disturbances and sleep disorders as risk factors for chronic postsurgical pain: a systematic review and meta-analysis. Sleep Med. Rev. 63, 101630. doi: 10.1016/j.smrv.2022.101630
Wagenmakers, E. J., and Brown, S. (2007). On the linear relation between the mean and the standard deviation of a response time distribution. Psychol. Rev. 114, 830–841. doi: 10.1037/0033-295X.114.3.830
Xue, C., Ge, Y., Tang, B., Liu, Y., Kang, P., Wang, M., et al. (2015). A meta-analysis of risk factors for combat-related PTSD among military personnel and veterans. PLoS One 10:e0120270. doi: 10.1371/journal.pone.0120270
Yavne, Y., Amital, D., Watad, A., Tiosano, S., and Amital, H. (2018). A systematic review of precipitating physical and psychological traumatic events in the development of fibromyalgia. Semin. Arthritis Rheum. 48, 121–133. doi: 10.1016/j.semarthrit.2017.12.011
Keywords: chronic pain, neuropsychology, attention, continuous performance, cognition
Citation: Schmidt SL, Araguez IM, Neves VV, van Duinkerken E, Schmidt GJ, Tolentino JC and Gjorup ALT (2022) Attention deficits in Brazilian health care workers with chronic pain. Front. Psychol. 13:1024584. doi: 10.3389/fpsyg.2022.1024584
Received: 21 August 2022; Accepted: 03 October 2022;
Published: 24 October 2022.
Edited by:
Federica Galli, Sapienza University of Rome, ItalyReviewed by:
Timothy Joseph Meeker, Morgan State University, United StatesGiorgia Varallo, University of Parma, Italy
Copyright © 2022 Schmidt, Araguez, Neves, van Duinkerken, Schmidt, Tolentino and Gjorup. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Sergio L. Schmidt, c2xzY2htaWR0QHRlcnJhLmNvbS5icg==
†These authors share first authorship